Our Mission

Creating innovative Transdermal PRODUCTS for PATIENTS, PHYSICIANS and PAYERS

A brand new era of drug delivery...
Work with 4P Therapeutics...


4P develops Products that meet the needs of Patients, Physicians, and Payers.


Developing both passive and novel transdermal systems for generics, new chemical entities, biologics, and differentiated products.


Integrated development capabilities, from proof-of-concept to Phase I Clinical testing, and process development and manufacturing

4P Overview

4P Therapeutics is a clinical subsidiary of Nutriband Inc. (NTRB) focused on the research and development of novel drug delivery technologies and therapeutics. 4P develops products that meet the needs of patients, physicians and payers.

About 4P Therapeutics

The company has capabilities for developing pharmaceutical products from pre-clinical testing to clinical manufacturing and early stage clinical development (Phase I/II). A key company focus and area of expertise is in the development of transdermal products for currently injected compounds, including proteins, peptides, macromolecules and biologics. Transdermal delivery of commercially available drugs or biologics that are typically delivered via injection has the potential to improve safety, efficacy and therapeutic outcomes associated with these treatments.

Visit Nutriband Pharma
Contact us